Journal of Clinical Trials, Pathology and Case Studies

Next-generation tumor profiling identified high total mutation burden (TMB) in Lymphoepithelioma-like carcinoma of the urinary bladder (LELCB): A potential rationale for Immunotherapy

– Jue Wang